Trial Profile
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 3 Trial to Assess the Efficacy and Safety of Tobramycin Inhalation Powder (TIP) in Cystic Fibrosis (CF) Subjects.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 14 Oct 2011
Price :
$35
*
At a glance
- Drugs Tobramycin (Primary)
- Indications Cystic fibrosis-associated respiratory tract infections; Pseudomonal infections
- Focus Registrational; Therapeutic Use
- Acronyms EVOLVE
- Sponsors Chiron Corporation; Novartis
- 16 Jun 2009 New trial record